about
Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible CrosstalkWnt signaling in neuropsychiatric disorders: ties with adult hippocampal neurogenesis and behaviorMicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/β-catenin signaling pathwayMining TCGA data using Boolean implicationsThermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR GammaHOTAIR is a therapeutic target in glioblastoma.HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challengesAlterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells.Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival.Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disordersOverexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ.MicroRNA-566 activates EGFR signaling and its inhibition sensitizes glioblastoma cells to nimotuzumab.The Role of Wnt Signaling in Squamous Cell Carcinoma.WNT signaling in glioblastoma and therapeutic opportunities.Glycoprotein non-metastaticmelanoma protein B promotes glioma motility and angiogenesis through the Wnt/β-catenin signaling pathway.Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling.MSX1 inhibits cell migration and invasion through regulating the Wnt/β-catenin pathway in glioblastoma.Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.How Wnt Signaling Builds the Brain: Bridging Development and Disease.Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.β-catenin-mediated YAP signaling promotes human glioma growth.Wnt/β-catenin up-regulates Midkine expression in glioma cells.The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2.lncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma.Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.Expression profile and clinical significance of Wnt signaling in human gliomas.miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway.Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.LncRNAs regulate cancer metastasis via binding to functional proteins.Long non-coding RNA MEG3 promotes the proliferation of glioma cells through targeting Wnt/β-catenin signal pathway.MicroRNA miR-1249 downregulates adenomatous polyposis coli 2 expression and promotes glioma cells proliferation.Propofol inhibits Wnt signaling and exerts anticancer activity in glioma cells.Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.
P2860
Q26865911-9EE0376D-B2F1-47AE-8AB8-A9585E77E1B0Q27008843-E1DF774D-188A-4C39-A66D-0371130A5A72Q28115534-87572017-8FA5-46A5-8B85-C07888A905D4Q30838107-8EE296DE-9254-486E-8444-9B6E0494B962Q33748280-8FA398B0-8310-4348-A787-33FC2061E6B7Q35781595-8393EC6F-8141-45D7-8A53-7D25C3610BA5Q36413906-2FEB3DB7-27FE-4013-BC5D-B7634D443CDCQ36524716-8B60759E-C538-495A-A6C4-143F18D61E46Q36633528-E22A3F3C-10E8-42F1-A147-607458769F91Q36795811-C03E2FF5-B168-4A80-BC9D-36EFAE745DDAQ36949561-FBF48AC1-7DD4-43A1-969B-F4CB0CFCB837Q37699166-C1F097AF-1D34-4FE6-BD6C-95C1206A5A6AQ37723702-64E2BB43-B720-4E8D-922A-20E0A574B91AQ38620060-4C388AAD-8244-4F97-9772-8E4C7EB3671EQ38660744-5E3200E1-6966-4DF0-BB30-2FB13042CCA3Q38762752-86793499-2C50-4CEB-AE73-D9468273C13CQ38767738-8A6AC8F2-021C-4EFE-BA40-A8D834848560Q38843933-330FA4DD-1633-4E46-B7AB-1C8F08906D24Q38848185-C132B7C4-6271-4186-BA32-F2771953C40EQ38900748-509ACDF1-883B-4718-A878-16F3A8DD3BB8Q38953710-A1D5D6EA-6350-41E8-9737-61A24D02CCBEQ39090175-D1B1386B-B5CC-409F-9455-EF8AC9C50BF6Q41809872-B154AF8E-0950-4DBF-81D4-CBC1D5DA9B9DQ41971317-1E322050-C471-44F1-A20D-8E9845F00F50Q42874062-C5A7055D-49DD-4ED4-A1FE-7BC82D6CBF0EQ47116860-E7886FC2-FBB8-4DB0-B35F-87F35E7998ECQ47133782-7DE46A02-7009-4EE0-9281-18367355237EQ47294523-0C9F5D96-F7FA-4CE5-B678-CAAD409AC4A0Q47330690-D1891B75-EA60-43CC-8D24-8DCB6678098DQ47827635-B9807509-38A5-415C-AE87-BF8D0D006E94Q48334053-A1CBC22D-2D95-41DF-B7F5-312F2D49A426Q48507293-7C5E4C05-6293-4BA1-A12E-0787FC49D6E3Q49263865-2FCA5961-579B-41F6-9126-9A04DDCCF68FQ49740926-8BD5E81C-0F65-4DB6-A714-382A22BF8B4AQ50063064-D7D211EA-B16D-4C94-9C80-F3803BE2D2ADQ54975281-8D73D792-4805-46EE-83F2-4C57E3D7B408Q55279534-482AC9DE-7576-49A9-BBD9-2E83415F342DQ55457391-212ECFD0-97CA-4794-9A5B-7EE10FDFBFD0
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Wnt/beta-catenin signaling in glioma.
@en
Wnt/beta-catenin signaling in glioma.
@nl
type
label
Wnt/beta-catenin signaling in glioma.
@en
Wnt/beta-catenin signaling in glioma.
@nl
prefLabel
Wnt/beta-catenin signaling in glioma.
@en
Wnt/beta-catenin signaling in glioma.
@nl
P2093
P2860
P1476
Wnt/beta-catenin signaling in glioma.
@en
P2093
Chunsheng Kang
Junxia Zhang
Kailiang Zhang
P2860
P2888
P304
P356
10.1007/S11481-012-9359-Y
P577
2012-03-28T00:00:00Z